MarketCap
Facebook
X
Telegram
Country |
 Schweiz |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
102 M |
Market Cap[1] |
$ 1.1 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market |  USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.81 | 1.81 % | $ 91.2 K | Nasdaq Capital Market | USA |
|
Biodesix
BDSX
|
$ 27.16 | 0.7 % | $ 205 M | Nasdaq Global Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market |  Israel |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.28 | 1.79 % | $ 6.65 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.34 | 9.81 % | $ 7.3 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 11.75 | 5.68 % | $ 124 M | Nasdaq Global Market |  China |
 |
Bioventus
BVS
|
$ 13.21 | 1.77 % | $ 880 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 52.06 | 3.58 % | $ 2.77 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 83.18 | 0.07 % | $ 3.89 B | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 1.14 | 1.83 % | $ 1.52 M | Nasdaq Capital Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 269.68 | 0.06 % | $ 13.4 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 32.99 | 2.04 % | $ 956 M | Nasdaq Global Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 237.41 | 1.06 % | $ 26.4 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 202.7 | 1.27 % | $ 144 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.1 | 2.45 % | $ 28.3 M | Nasdaq Capital Market | Israel |
 |
Brainsway Ltd.
BWAY
|
$ 13.66 | 0.14 % | $ 464 M | Nasdaq Global Select Market | Israel |
 |
DexCom
DXCM
|
$ 84.28 | 1.5 % | $ 32.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 20.51 | 0.29 % | $ 631 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 163.86 | 4.11 % | $ 20.5 B | Nasdaq Global Select Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 169.16 | 0.97 % | $ 13.3 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 507.97 | 0.65 % | $ 40.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 208.08 | 0.79 % | $ 32.3 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 264.32 | 0.98 % | $ 45.4 B | NYSE,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 311.9 | 0.1 % | $ 26 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.28 | 0.02 % | $ 6.77 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 591.59 | 0.69 % | $ 17.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 287.29 | 1.01 % | $ 26.5 B | NYSE,SPB | Schweiz |
 |
Myriad Genetics
MYGN
|
$ 3.66 | 7.02 % | $ 339 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.68 | 0.98 % | $ 4.47 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 17.9 | 3.35 % | $ 2.29 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.86 | 0.64 % | $ 2.58 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 22.12 | 4.71 % | $ 495 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 336.64 | 2.34 % | $ 46 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.56 | 0.38 % | $ 1.17 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.36 | 4.23 % | $ 408 M | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 25.17 | 2.28 % | $ 23.9 B | NYSE |  Niderland |
 |
Personalis
PSNL
|
$ 16.33 | 0.74 % | $ 1.46 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.